NDC 59148-011 – Abilify
Aripiprazole 30 mg/1 · Tablet · Oral
Product NDC59148-011
Product details
- Brand name
- Abilify
- Generic name
- Aripiprazole
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA021436
- Marketed since
- November 15, 2002
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Aripiprazole 30 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59148-011-13 | 30 TABLET in 1 BOTTLE, PLASTIC (59148-011-13) | Nov 15, 2002 |
| 59148-011-35 | 100 TABLET in 1 BLISTER PACK (59148-011-35) | Nov 15, 2002 |
Recalls mentioning this NDC
- D-0466-2024 May 1, 2024 · Class III
Cross Contamination with Other Products - D-0468-2024 May 1, 2024 · Class III
Cross Contamination with Other Products - D-0467-2024 May 1, 2024 · Class III
Cross Contamination with Other Products - D-0469-2024 May 1, 2024 · Class III
Cross Contamination with Other Products - D-181-2013 Mar 13, 2013 · Class II
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Other Abilify products
- 59148-006 Aripiprazole 2 mg/1 · Tablet · Otsuka America Pharmaceutical, Inc.
- 59148-007 Aripiprazole 5 mg/1 · Tablet · Otsuka America Pharmaceutical, Inc.
- 59148-008 Aripiprazole 10 mg/1 · Tablet · Otsuka America Pharmaceutical, Inc.
- 59148-009 Aripiprazole 15 mg/1 · Tablet · Otsuka America Pharmaceutical, Inc.
- 59148-010 Aripiprazole 20 mg/1 · Tablet · Otsuka America Pharmaceutical, Inc.